Pediatric HIV-1 Acquisition and Lifelong Consequences of Infant Infection

Cody S Nelson1, Genevieve G A Fouda1, Sallie R Permar1

  • 1Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.

Current Immunology Reviews
|November 23, 2020
PubMed

Insights

Despite advances in antiretroviral therapy, over 170,000 children still acquire HIV annually. Understanding immune factors is crucial for developing targeted therapies to prevent mother-to-child HIV transmission (MTCT).

Area of Science:

  • Immunology
  • Virology
  • Public Health

Background:

  • Antiretroviral therapy (ART) has significantly reduced HIV vertical transmission, but implementation challenges persist, leading to over 170,000 pediatric HIV infections annually.
  • Mother-to-child transmission (MTCT) of HIV-1 occurs via intrauterine, intrapartum, or postpartum routes, complicated by the diverse maternal-fetal interface.
  • Pediatric HIV infection remains a global health challenge, necessitating novel strategies beyond current ART protocols.

Purpose of the Study:

  • To investigate the biological mechanisms underlying pediatric HIV infection.
  • To identify unique immune factors that confer protection against different modes of HIV MTCT.
  • To inform the development of targeted immune interventions for preventing infant HIV acquisition.

Main Methods:

  • Analysis of mother-infant human cohorts.
  • Utilizing nonhuman primate models for simian immunodeficiency virus (SIV) acquisition studies.
  • Investigating the maternal-fetal interface in the context of HIV transmission.

Main Results:

  • Observations on the biology of pediatric HIV infection have been made.
  • Unique protective immune factors have been identified for distinct MTCT routes.
  • The heterogeneity of the maternal-fetal interface presents challenges for immune intervention.

Conclusions:

  • Knowledge of protective immune factors is critical for preventing infant HIV acquisition.
  • Targeted immune therapies are essential to eradicate the pediatric AIDS epidemic.
  • Further research into immune responses at different stages of MTCT is warranted.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.6K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
643
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
563
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
599